← Browse by Condition
Medical Condition

recurrent acute undifferentiated leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06928662 Phase 1, Phase 2
Recruiting

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
View Trial →